| |
|
|
|
Antares Pharma Inc.  
|
|
2.81 -0.01 (-0%) |
05-23 13:21 |
|
Open: |
2.8 |
Pre close: |
2.82 |
Target:
|
3.40
|
|
High: |
2.84 |
Low: |
2.7637 |
Resistance:
|
2.92
3.11
|
|
Volume: |
222,092 |
Market Cap: |
457M |
Support:
|
2.60
2.16
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.80
 |
MACD |
MACD(12,26):
|
-0.04  |
|
MA(20): |
2.87 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
3.09 |
Stochastic Oscillator |
%K(14,3):
|
33.05 |
|
MA(250): |
3.10 |
%D(3): |
34.27 |
|
Average Volume(K) |
3-Month: |
110263
|
52-Week |
High:
|
3.96 |
|
10-Days: |
65162 |
Low: |
2.40 |
|
RSI |
RSI(14):
|
45.33 |
Change(%): |
12.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.040 |
Return on Equity (ttm) |
-17.1 |
Shares Out. (M) |
162.62 |
|
EPS Est. Current Year |
-0.100 |
Return on Assets (ttm) |
-7.2 |
Shares Float (M) |
146.86 |
|
EPS Est. Next Year |
0.010 |
PEG Ratio |
-0.63 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
83.3 |
% Held by Institutions |
54.50 |
|
Forward EPS |
0.050 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
10.860 |
EBITDA (p.s.) |
0.000 |
P/E |
-70.36 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.26 |
|
Profit Margin |
-8.13 |
Operating Cash Flow
(M) |
-23.28 |
P/S |
973747840.00 |
|
Operating Margin |
-21.53 |
Levered Free Cash Flow
(M) |
-25.16 |
P/CF |
-19.66 |
|
|
|
|
|
|
